US FDA probes tumour risk tied to Novartis gene therapy
Resumen detallado
ZURICH: The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated wit ...
The Swiss drugmaker Novartis earlier in the day disclosed two cases in which tumours in children showed evidence of being linked to its gene therapy drug
Novartis said that it had received nine reports overall of tumours in patients previously treated with Zolgensma since the therapy was first approved in 2019. The logo of Swiss drugmaker Novartis for illustrative purposes. (Reuters)
Inicio del artículo, extracto de Emirates 24/7. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.emirates247.com)
